// App-Quantinova.ai

OP089 : Meta-analysis of safety and efficacy of bivalirudin vs heparin with or without routine GPIIb/IIIa inhibitor in patients with acute coronary syndrome

Researchers

Presenter

  • Navarese E.P

Principal Investigators

  • Schulze V

  • Andreotti F

  • Kandzari D.E

  • Rassaf T

  • Brockmeyer M

  • Meyer C

  • Berti S

  • Valgimigli M

  • Kelm M

Medical Centers

  • Heinrich-Heine-Universitat, Dusseldorf, Germany

  • Fondazione Monasterio-CNR, Pisa, Italy

  • Catholic University of Rome, Rome, Italy

Locations

  • Germany

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • Glycosylphosphatidylinositol

Drug/Treatment

  • Bivalirudin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved